vimarsana.com

Page 5 - ப்ராடக்ட்ஸ் நிறுவனம் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

World Insights: European countries eyeing Chinese COVID-19 vaccines amid delivery crisis

news World Insights: European countries eyeing Chinese COVID-19 vaccines amid delivery crisis unreguser,Shi Zhongyu,Zhu Sheng,Yuan Liang,Sun Yifei,Zhao Feifei © Provided by N.C.N. Limited Workers unload a container of China s Sinopharm inactivated coronavirus vaccines at the Belgrade Airport, Serbia, Jan. 16, 2021. (Photo by Predrag Milosavljevic/Xinhua) People here are very satisfied and we are very proud that we succeeded in delivering such good things for the better health of our people and for the future of this country, said Serbian President Aleksandar Vucic. BELGRADE, Feb. 15 (Xinhua) As Hungary joined Serbia in spearheading mass inoculation with China s Sinopharm COVID-19 vaccine in Europe, other European countries are struggling against a vaccine delivery crisis and exploring a way out of lockdown and into economic recovery.

Over 31 million doses of COVID-19 vaccine administered in China

Published February 6, 2021, 10:30 AM BEIJING  More than 31 million doses of COVID-19 vaccine had been administered in China as of Feb. 3, according to China’s National Health Commission. Preliminary tests showed that the incidence of severe abnormal reactions caused by the COVID-19 vaccines currently used in China is no higher than that of the influenza vaccine, said Xu Wenbo, head of the National Institute for Viral Disease Control and Prevention under the Chinese Center for Disease Control and Prevention. In late December 2020, an inactivated vaccine developed by Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), affiliated with Sinopharm, became the first to receive conditional market approval from the National Medical Products Administration.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.